| Kathleen M Boreale, NP | |
|
11 Overlook Road, Suite B110, Summit, NJ 07901-3577 | |
| (908) 522-2709 | |
| Not Available |
| Full Name | Kathleen M Boreale |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 23 Years |
| Location | 11 Overlook Road, Summit, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043299431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 26NJ0000080 (New Jersey) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 26NJ00000800 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epilepsy And Neurophysiology Medical Consultants Pa | 5395706501 | 20 |
News Archive
Caliber I.D. launches the RS-G4, a new class of modular confocal microscope that delivers confocal's expected high resolution and clean contrast while overcoming its limited scan areas.
Regulus Therapeutics Inc. announced today that advancements from its leading microRNA platform and product pipeline were presented at the "6th Annual Meeting of the Oligonucleotide Therapeutics Society" held October 20 - 23, 2010 in Dana Point, California.
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
UNIQUE PHARMACEUTICALS, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, today announced its licensure approval in Florida. The Florida State Board of Pharmacy review committee approved Unique Pharmaceuticals' license June 10 for distribution of sterile and non-sterile compounded medications.
› Verified 4 days ago
| Entity Name | Epilepsy & Neurophysiology Medical Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013998830 PECOS PAC ID: 5395706501 Enrollment ID: O20041021000286 |
News Archive
Caliber I.D. launches the RS-G4, a new class of modular confocal microscope that delivers confocal's expected high resolution and clean contrast while overcoming its limited scan areas.
Regulus Therapeutics Inc. announced today that advancements from its leading microRNA platform and product pipeline were presented at the "6th Annual Meeting of the Oligonucleotide Therapeutics Society" held October 20 - 23, 2010 in Dana Point, California.
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
UNIQUE PHARMACEUTICALS, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, today announced its licensure approval in Florida. The Florida State Board of Pharmacy review committee approved Unique Pharmaceuticals' license June 10 for distribution of sterile and non-sterile compounded medications.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen M Boreale, NP 158 W 27th St, 11th Floor South, New York, NY 10001-6216 Ph: (212) 563-2497 | Kathleen M Boreale, NP 11 Overlook Road, Suite B110, Summit, NJ 07901-3577 Ph: (908) 522-2709 |
News Archive
Caliber I.D. launches the RS-G4, a new class of modular confocal microscope that delivers confocal's expected high resolution and clean contrast while overcoming its limited scan areas.
Regulus Therapeutics Inc. announced today that advancements from its leading microRNA platform and product pipeline were presented at the "6th Annual Meeting of the Oligonucleotide Therapeutics Society" held October 20 - 23, 2010 in Dana Point, California.
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
UNIQUE PHARMACEUTICALS, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, today announced its licensure approval in Florida. The Florida State Board of Pharmacy review committee approved Unique Pharmaceuticals' license June 10 for distribution of sterile and non-sterile compounded medications.
› Verified 4 days ago